Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial

Documenti analoghi

• Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials
  di: Bian, Helen, et al.
  Pubblicazione: (2024)
• Caring for caregivers in early‐phase clinical oncology trials
  di: Leah L. Thompson, et al.
  Pubblicazione: (2025)
• Investigational Use of Real‐World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial
  di: Andrew H. Ko, et al.
  Pubblicazione: (2024)
• U-DESPE: a Bayesian Utility-based methodology for dosing regimen optimization in early-phase oncology trials based on Dose-Exposure, Safety, Pharmacodynamics, Efficacy
  di: Andrillon, Anaïs, et al.
  Pubblicazione: (2025)
• Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship
  di: Jenny Ruiz, et al.
  Pubblicazione: (2024)